Clinical Trial Update: Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating transcutaneous non-invasive vagus nerve stimulation (t-VNS) for schizophrenia has completed. The sponsor listed is cerbom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Transcutaneous non-invasive vagus nerve stimulation (t-VNS) (transcutaneous vagus nerve stimulation)

Snippet

Sponsor: cerbomed GmbH | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED